Overview
Abstract Submissions
Case Submission
Satellite Symposia
Keynote
Faculty
Opportunities
Agenda
Accommodations
Multimedia
Resources

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit http://www.absurgery.org

Acknowledgment of Commercial Support

The 36th Annual Miami Breast Cancer Conference®(MBC) is supported by educational grants from AbbVie Inc., AstraZeneca, Celgene Corporation, Daiichi Sankyo, Inc., Eisai, Genentech, Inc., Genomic Health, Inc., Lilly, Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., Pfizer, Puma Biotechnology, Inc., and Seattle Genetics, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

36th Annual Miami Breast Cancer Conference®

36th Annual Miami Breast Cancer Conference®


March 7-10, 2019
Fontainebleau Miami Beach
4441 Collins Avenue
Miami Beach, FL 33140

36th Annual Miami Breast Cancer Conference Overview

The optimal care of patients with breast cancer is rapidly changing and becoming increasingly complex as a result of advances in all aspects of management, including screening, molecular/genetic testing, detection, primary treatments (ie, surgery, radiation therapy, and systemic therapies), and patient support strategies. For 36 years, the multidisciplinary Miami Breast Cancer Conference® has been bringing together surgical, medical, and radiation oncologists, as well as geneticists, pathologists, radiologists, and supportive care specialists, with the aim of fostering your awareness of state-of-the-art treatments for all stages and subtypes of breast cancer, providing you with expert perspectives on areas of clinical uncertainty or controversy, and encouraging you to engage in cross-team cooperation in your clinic. This year will be no different and will also include a patient communication workshop, specialized programming on issues related to young women with breast cancer, and a frank discussion about physician burnout. Please join us at the 36th Annual Miami Breast Cancer Conference®.

Benefits of Attending an Oncology CME, presented by PER

  • Network with your peers
  • Ask world-renowned thought leaders your important questions
  • Obtain clarity on areas of clinical uncertainty and controversy that you encounter in your practice
  • Gain a higher level of understanding of complex data sets
  • Learn how to apply the latest evidence, therapies, and strategies in your practice, including molecular, genetic, and genomic information

Acknowledgment of Commercial Support

The 36th Annual Miami Breast Cancer Conference®(MBC) is supported by educational grants from AbbVie Inc., AstraZeneca, Celgene Corporation, Daiichi Sankyo, Inc., Eisai, Genentech, Inc., Genomic Health, Inc., Lilly, Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., Pfizer, Puma Biotechnology, Inc., and Seattle Genetics, Inc.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Learning Objectives

  • Incorporate molecular and genomic biomarkers, multi-gene prognostic assays, and tumor subtype information, in appropriate patients to inform clinical decision-making and optimize outcomes for individual patients
  • Summarize expert guidelines and evidence from clinical trials that supports the use of genomic and molecular tools to individualize and inform treatment decisions for patients with early and advanced stages of breast cancer
  • Coordinate evidence-based multimodal treatment strategies, integrating surgery, radiation, and systemic therapy when appropriate, to optimize outcomes for patients with non-metastatic breast cancer
  • Implement multidisciplinary strategies to prevent, mitigate, or manage treatment-related adverse events for patients with breast cancer
  • Integrate recent clinical trial data and expert guidelines into evolving treatment standards in order to provide state-of-the-art care for patients with breast cancer

MBC Mini-Symposium

Don’t miss the Thursday Mini-Symposium at the 36th Annual Miami Breast Cancer Conference®, now in a new format! For years, the MBC Mini-Symposium has been a popular educational add-on option. In 2019, this special session will truly follow the format of the Tumor Boards taking place at cancer care institutions around the world. Throughout the day, a series of 15 to 20 breast cancer patient cases will be presented, each highlighting an important clinical challenge being faced by breast cancer care providers like you. A world-class multidisciplinary clinical team, composed of members of the MBC faculty, will share their approaches and perspectives for the questions at hand in the context of current evidence and best practices, with the ultimate goal of reaching consensus toward management. This special session, to be delivered by top experts in the field of breast cancer, was developed to be of interest to practitioners from all specialties, and will provide practical information to enhance patient care in your clinic.

If your schedule allows, we at Physicians' Education Resource hope you will plan to attend and take advantage of this valuable extra session!

Note: Separate registration is required.

Program Chair

Patrick I. Borgen, MDPatrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
Brooklyn, NY
 
 

Program Co-Chairs

Elizabeth Mittendorf, MDElizabeth Mittendorf, MD, PhD
Robert and Karen Hale Distinguished Chair in Surgical Oncology
Director, Breast Immuno-Oncology Program
Dana-Farber/Brigham and Women's Cancer Center
Boston, MA
 

Hope S. Rugo, MDHope S. Rugo, MD, FASCO
Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
 

Debu Tripathy, MDDebu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
 



For more on this oncology CME, view highlights from last year's meeting.

 
*Discount does not apply to the Mini-Symposium or Guest Registration.
**FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount.
***INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
 
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 25% will be assessed on refunds requested through and including January 27, 2019, and a 50% fee on refunds requested on January 28, 2019, through February 24, 2019. No refunds will be made after February 24, 2019. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians’ Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians’ Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity (“Events”), all participants, attendees, exhibitors, sponsors, and guests (“you”) create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness (“Image”).  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.

Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By